FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891380366> ?p ?o ?g. }

• W2891380366 abstract "Multidrug resistance (MDR) is a major obstacle in breast cancer treatment. The predominant mechanism underlying MDR is an increase in the activity of adenosine triphosphate (ATP)-dependent drug efflux transporters. Sulbactam, a β-lactamase inhibitor, is generally combined with β-lactam antibiotics for treating bacterial infections. However, sulbactam alone can be used to treat Acinetobacter baumannii infections because it inhibits the expression of ATP-binding cassette (ABC) transporter proteins. This is the first study to report the effects of sulbactam on mammalian cells.We used the breast cancer cell lines as a model system to determine whether sulbactam affects cancer cells. The cell viabilities in the present of doxorubicin with or without sulbactam were measured by MTT assay. Protein identities and the changes in protein expression levels in the cells after sulbactam and doxorubicin treatment were determined using LC-MS/MS. Real-time reverse transcription polymerase chain reaction (real-time RT-PCR) was used to analyze the change in mRNA expression levels of ABC transporters after treatment of doxorubicin with or without sulbactam. The efflux of doxorubicin was measures by the doxorubicin efflux assay.MTT assay revealed that sulbactam enhanced the cytotoxicity of doxorubicin in breast cancer cells. The results of proteomics showed that ABC transporter proteins and proteins associated with the process of transcription and initiation of translation were reduced. The mRNA expression levels of ABC transporters were also decreased when treated with doxorubicin and sulbactam. The doxorubicin efflux assay showed that sulbactam treatment inhibited doxorubicin efflux.The combination of sulbactam and doxorubicin enhances the cytotoxicity of doxorubicin in the breast cancer cells by inhibiting the expression of ABC transporter proteins and proteins associated with the process of transcription and initiation of translation, and blocking the efflux of doxorubicin. Co-treatment of doxorubicin and sulbactam can be used in breast cancer treatment to decrease the prescribed dose of doxorubicin to avoid the adverse effects of doxorubicin." @default.
• W2891380366 created "2018-09-27" @default.
• W2891380366 creator A5015078427 @default.
• W2891380366 creator A5017485769 @default.
• W2891380366 creator A5040735753 @default.
• W2891380366 creator A5043910595 @default.
• W2891380366 creator A5063718784 @default.
• W2891380366 date "2018-09-04" @default.
• W2891380366 modified "2023-10-17" @default.
• W2891380366 title "Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells" @default.
• W2891380366 cites W1271389891 @default.
• W2891380366 cites W1518490346 @default.
• W2891380366 cites W1543790510 @default.
• W2891380366 cites W1549517261 @default.
• W2891380366 cites W1550451411 @default.
• W2891380366 cites W1566266557 @default.
• W2891380366 cites W1751582566 @default.
• W2891380366 cites W1981140460 @default.
• W2891380366 cites W1986944635 @default.
• W2891380366 cites W1988343883 @default.
• W2891380366 cites W1991366673 @default.
• W2891380366 cites W1992574593 @default.
• W2891380366 cites W1997522298 @default.
• W2891380366 cites W2000021455 @default.
• W2891380366 cites W2006375570 @default.
• W2891380366 cites W2008476897 @default.
• W2891380366 cites W2011381671 @default.
• W2891380366 cites W2013956549 @default.
• W2891380366 cites W2017323433 @default.
• W2891380366 cites W2030833199 @default.
• W2891380366 cites W2033346155 @default.
• W2891380366 cites W2034979953 @default.
• W2891380366 cites W2046645061 @default.
• W2891380366 cites W2055904567 @default.
• W2891380366 cites W2056772956 @default.
• W2891380366 cites W2068345616 @default.
• W2891380366 cites W2070243196 @default.
• W2891380366 cites W2072001961 @default.
• W2891380366 cites W2076295610 @default.
• W2891380366 cites W2086034451 @default.
• W2891380366 cites W2093576033 @default.
• W2891380366 cites W2096171066 @default.
• W2891380366 cites W2096535852 @default.
• W2891380366 cites W2098885754 @default.
• W2891380366 cites W2100730637 @default.
• W2891380366 cites W2104582297 @default.
• W2891380366 cites W2110790042 @default.
• W2891380366 cites W2115434559 @default.
• W2891380366 cites W2119538132 @default.
• W2891380366 cites W2122412604 @default.
• W2891380366 cites W2145796553 @default.
• W2891380366 cites W2148287035 @default.
• W2891380366 cites W2151895972 @default.
• W2891380366 cites W2165343618 @default.
• W2891380366 cites W2170552969 @default.
• W2891380366 cites W2290185180 @default.
• W2891380366 cites W2301188205 @default.
• W2891380366 cites W2375287196 @default.
• W2891380366 cites W2381727044 @default.
• W2891380366 cites W2401073890 @default.
• W2891380366 cites W2598329206 @default.
• W2891380366 cites W4236952879 @default.
• W2891380366 cites W1762847686 @default.
• W2891380366 doi "https://doi.org/10.1186/s12935-018-0625-9" @default.
• W2891380366 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6123926" @default.
• W2891380366 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30202239" @default.
• W2891380366 hasPublicationYear "2018" @default.
• W2891380366 type Work @default.
• W2891380366 sameAs 2891380366 @default.
• W2891380366 citedByCount "42" @default.
• W2891380366 countsByYear W28913803662019 @default.
• W2891380366 countsByYear W28913803662020 @default.
• W2891380366 countsByYear W28913803662021 @default.
• W2891380366 countsByYear W28913803662022 @default.
• W2891380366 countsByYear W28913803662023 @default.
• W2891380366 crossrefType "journal-article" @default.
• W2891380366 hasAuthorship W2891380366A5015078427 @default.
• W2891380366 hasAuthorship W2891380366A5017485769 @default.
• W2891380366 hasAuthorship W2891380366A5040735753 @default.
• W2891380366 hasAuthorship W2891380366A5043910595 @default.
• W2891380366 hasAuthorship W2891380366A5063718784 @default.
• W2891380366 hasBestOaLocation W28913803661 @default.
• W2891380366 hasConcept C104317684 @default.
• W2891380366 hasConcept C109316439 @default.
• W2891380366 hasConcept C114851261 @default.
• W2891380366 hasConcept C121608353 @default.
• W2891380366 hasConcept C126322002 @default.
• W2891380366 hasConcept C133936738 @default.
• W2891380366 hasConcept C149011108 @default.
• W2891380366 hasConcept C153911025 @default.
• W2891380366 hasConcept C185592680 @default.
• W2891380366 hasConcept C200082930 @default.
• W2891380366 hasConcept C202751555 @default.
• W2891380366 hasConcept C2776694085 @default.
• W2891380366 hasConcept C2778478555 @default.
• W2891380366 hasConcept C2778707650 @default.
• W2891380366 hasConcept C2779631663 @default.
• W2891380366 hasConcept C2780783641 @default.
• W2891380366 hasConcept C2781303535 @default.
• W2891380366 hasConcept C44312359 @default.

• next